The role of tricyclic drugs in selective triggering of mitochondrially- mediated apoptosis in neoplastic glia: A therapeutic option in malignant glioma?

Radiology and Oncology

Volumn 40, Issue 2, 2006, Pages 73-85

  Pilkington, Geoffrey J ^a   Akinwunmi, James ^b   Amar, Sabrina ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b Haywards Heath West Sussex   (United Kingdom)

Author keywords

Antidepressive agents, tricyclic; Apoptosis; Brain neoplasms drug therapy; Clomipramine; Glioma

Indexed keywords

AMITRIPTYLINE; CASPASE 3; CD133 ANTIGEN; CITALOPRAM; CLOMIPRAMINE; CYTOCHROME C; CYTOCHROME P450; DEXAMETHASONE; DOXEPIN; NORCLOMIPRAMINE; NORTRIPTYLINE; REACTIVE OXYGEN METABOLITE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ASTROCYTE; BRAIN TUMOR; CLINICAL TRIAL; DRUG METABOLISM; DRUG STRUCTURE; GLIOBLASTOMA; HUMAN; LYMPHOMA; MITOCHONDRION; RESPIRATORY CHAIN; REVIEW;

EID: 33746640986     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Linstead D, Wilkie D. A comparative study of in vivo inhibition of mitochondrial function in Saccharomyces cerevisiae by tricyclic and other centrally-acting drugs. Biochem Pharmacol 1971; 20: 839-46.
2. Wilkie D. Antimitochondrial drugs in cancer chemotherapy: preliminary communication. J Roy Soc Med 1979; 72: 599-601.
3. Rooprai HK, Christidou M, Pilkington GJ. The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas. Acta Neurochir (Wien) 2003; 145: 683-90.
4. Eto K, Fukuda T, Araki Y, Inoue B, Ogata M. Effect of tricyclic drugs on mitochondrial membrane. Acta Med Okayama 1985; 39: 289-95.
5. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett 2004; 149: 19-23.
6. Warburg O. On the origin of cancer cells. Science 1956; 123(3191): 309-14.
7. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281(5381): 1309-12.
8. Vaux DL. Apoptosis and toxicology - what relevance? Toxicology 2002; 181-182: 3-7.
9. Amirlak B, Couldwell WT. Apoptosis in glioma cells: review and analysis of techniques used for study with focus on the laser scanning cytometer. J Neurooncol 2003; 63: 129-45.
10. Julien T, Frankel B, Longo S, Kyle M, Gibson S, Shillitoe E, et al. Antisense-mediated inhibition of the bcl-2 gene induces apoptosis in human malignant glioma. Surg Neurol 2000; 53: 360-9.
11. Glaser T, Weller M. Caspase-dependent chemotherapy-induced death of glioma cells requires mitochondrial cytochrome c release. Biochem Biophys Res Commun 2001; 281: 322-7.
12. Morisaki T, Katano M. Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer. Curr Med Chem 2003; 10: 2517-21.
13. Xia Z, Bergstrand A, DePierre JW, Nassberger L. The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol 1999; 13: 338-47.
14. Xia Z, Lundgren B, Bergstrand A, DePierre JW, Nassberger L. Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and Bcl-X(L). Biochem Pharmacol 1999; 57: 1199-208.
15. Meredith EJ, Holder MJ, Chamba A, Challa A, Drake-Lee A, Bunce CM, et al. The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics. Faseb J 2005; 19: 1187-9.
16. Daley E, Wilkie D, Loesch A, Hargreaves IP, Kendall DA, Pilkington GJ, et al. Chlorimipramine: a novel anticancer agent with a mitochondrial target. Biochem Biophys Res Commun 2005; 328: 623-32.
17. Spanova A, Kovaru H, Lisa V, Lukasova E, Rittich B. Estimation of apoptosis in C6 glioma cells treated with antidepressants. Physiol Res 1997; 46: 161-4.
18. Merry S, Hamilton TG, Flanigan P, Freshney RI, Kaye SB. Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine. Eur J Cancer 1991; 65: 31-4.
19. Pommerenke EW, Volm M. Reversal of doxorubicin-resistance in solid tumors by clomipramine. In Vivo 1995; 9: 99-101.
20. Varga A, Nugel H, Baehr R, Marx U, Hever A, Nacsa J, et al. Reversal of multidrug resistance by amitriptyline in vitro. Anticancer Res 1996; 16: 209-11.
21. Volpe DA, Ellison CD, Parchment RE, Grieshaber CK, Faustino PJ. Effects of amitriptyline and fluoxetine upon the in vitro proliferation of tumor cell lines. J Exp Ther Oncol 2003; 3: 169-84.
22. Swaroops GR, Kelly PA, Holmes MC, Shinoda J, Whittle IR. The effects of dexamethasone therapy on permeability, blood flow and iNOS expression in experimental glioma. J Clin Neurosci 2001; 8: 35-9.
23. Gorman AM, Hirt UA, Orrenius S, Ceccatelli S. Dexamethasone pre-treatment interferes with apoptotic death in glioma cells. Neuroscience 2000; 96: 417-25.
24. Das A, Banik NL, Patel SJ, Ray SK. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Molecular Cancer 2004; 3: 36.
25. Sur P, Sribnick EA, Patel SJ, Ray SK, Banik NL. Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells. Glia 2005; 50: 160-7.
26. Amar S PK, R Lisle, G J Pilkington. Effect ofdexamethasone on the cytotoxic effect of clomipramine in human astrocytic cells in vitro. Journal of Neuro-oncology 2005; 7: 3.
27. Allabi AC, Gala JL, Desager JP, Heusterspreute M, Horsmans Y. Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations. Br J Clin Pharmacol 2003; 56: 653-7.
28. Yokono A, Morita S, Someya T, Hirokane G, Okawa M, Shimoda K. The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients. J Clin Psychopharmacol 2001; 21: 549-55.
29. Qi H, Chen HZ, Jin ZJ. Caspase 3 gene expression and [Ca2+]i homeostasis underlying desipramine-induced C6 glioma cell apoptosis. Acta Pharmacol Sin 2002; 23: 803-7.
30. Levkovitz Y, Gil-Ad I, Zeldich E, Dayag M, Weizman A. Differential induction of apoptosis by anti-depressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci 2005; 27: 29-42.
31. Levicar N, Dewey RA, Daley E, Bates TE, Davies D, Kos J, Pilkington GJ, Lah TT. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis. Cancer Gene Therapy 2002; 10: 141-51.
32. Pilkington G, Amar S, Parker K. Induction of apoptosis in glioma by tricyclics and selective serotonin reuptake inhibitors: laboratory and clinical studies. In: AACR. Proceedings, 96th Annual Meeting; Anaheim, USA, April 2005.
33. Merry S, Hamilton TG, Flanigan P, Freshney RI, Kaye SB. Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine. Eur J Cancer 1991; 27: 31-4.
34. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-12.
35. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 90: 5013-21.
36. Uchida K, Mukai M, Okano H, Kawase T. Possible oncogenicity of subventricular zone neural stem cells: case report. Neurosurgery 2004; 55: 977-8.
37. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-8.
38. Singh SK, Clarke ID, Hide T, Dirks PB. Cancer stem cells in nervous system tumors. Oncogene 2004; 23: 7267-73.
39. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004; 432(7015): 396-401.
40. Pilkington GJ. Cancer stem cells in the mammalian central nervous system. Cell Proliferation 2005; 38: 423-33.
41. Lee A, Kessler JD, Read TA, Kaiser C, Corbeil D, Huttner WB, et al. Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci 2005; 8: 723-9.
42. Stojkovic P, Lako M, Stewart R, Przyborski S, Armstrong L, Evans J, et al. An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells 2005; 23: 306-14.
43. Marchion DC, Bicaku E, Daud AI, Sullivan DM, Munster PN. Valproic acid alters chromatin structure by regulation of chromatin modulation proteins. Cancer Res 2005; 65: 3815-22.
44. Dote H, Cerna D, Burgan WE, Carter DJ, Cerra MA, Hollingshead MG, et al. Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine. Clin Cancer Res 2005; 11: 4571-9.
45. Beecken WD, Engl T, Ogbomo H, Relja B, Cinatl J, Bereiter-Hahn J, et al. Valproic acid modulates NCAM polysialylation and polysialyltransferase mRNA expression in human tumor cells. Int Immunopharmacol 2005; 5: 757-69.
46. Cinatl J, Jr., Cinatl J, Driever PH, Kotchetkov R, Pouckova P, Kornhuber B, et al. Sodium valproate inhibits in vivo growth of human neuroblastoma cells. Anticancer Drugs 1997; 8: 958-63.
47. Catalano MG, Fortunati N, Pugliese M, Costantino L, Poli R, Bosco O, et al. Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab 2005; 90: 1383-9.
48. Shen WT, Wong TS, Chung WY, Wong MG, Kebebew E, Duh QY, et al. Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells. Surgery 2005; 138: 979-85.
49. Koufali MM, Moutsatsou P, Sekeris CE, Breen KC. The dynamic localization of the glucocorticoid receptor in rat C6 glioma cell mitochondria. Mol Cell Endocrinol 2003; 209: 51-60.
50. Morita K, Ishimura K, Tsuruo Y, Wong DL. Dexamethasone enhances serum deprivation-induced necrotic death of rat C6 glioma cells through activation of glucocorticoid receptors. Brain Res 1999; 816: 309-16.
51. Goya L, Feng PT, Aliabadi S, Timiras PS. Effect of growth factors on the in vitro growth and differentiation of early and late passage C6 glioma cells. Int J Dev Neurosci 1996; 14: 409-17.
52. Renner K, Amberger A, Konwalinka G, Kofler R, Gnaiger E. Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells. Biochim Biophys Acta 2003; 1642: 115-23.